Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older at the time of enrolling in the trial.
- People who have been diagnosed with a large bulge (aneurysm) in the major blood vessel of the chest and/or abdomen that requires a specific type of internal repair using a custom-fitted device delivered through a tube 18 French (about 6mm) or larger in diameter.
- People whose hip/groin arteries (iliac arteries) are difficult to access due to heavy calcium buildup around the full circumference of the artery, a very narrow inner width (6mm or less), or significant blockage reducing blood flow.
- People whose aneurysm repair is needed urgently, is planned in advance (elective), is causing symptoms, or where the aneurysm is growing quickly.
- People whose procedure involved the use of a Shockwave™ device to treat the calcified arteries before the main repair device was inserted, with or without additional balloon widening or stent placement.
Who may not be able to join:
- People who had a surgical bypass procedure (a detour route surgically created to go around a blocked artery) to allow access for the repair.
- People whose arteries do not have severe calcium buildup, or have no calcium buildup at all.
- People who have a blockage or narrowing inside a previously placed stent in the relevant artery.
- People whose arteries could not be crossed with a very fine guidewire (a thin wire used to guide medical devices) during the procedure.
- People with a significant medical condition that, in the opinion of the medical team running the trial, could affect safe participation.
- People who already had a stent placed in the hip/groin arteries at the site where the Shockwave™ device would be used.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marc Bosiers, Dr., Rede Optimus Hospitalar AG
Phone: +49 157 80 58 5869
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy: Technical success - defined as intention-to-treat basis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.